MAX and anaplastic large cell lymphoma: As shown in Table 1, there were no significant differences in clinical features between MAX-positive and MAX-negative ALCL patients, such as invasion site (p = 0.295 to 1.000), clinical stage (p = 0.940), IPI (p = 0.940), and serum lactate dehydrogenase (p = 0.908).